How China Inc. Aims To Take Over Cell Therapy Dominance

Speed, Partnerships Shine for Small CAR-T Players

Nanjing, China
NANJING-BASED IASO, SET UP IN 2017, AIMS TO FILE ITS CAR-T THERAPY NEXT YEAR IN CHINA • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Gene Therapies

More from Advanced Therapies